본문바로가기

Other

메인페이지로 이동
Business
Life Science
ETC
혈액순환개선제
Novavax COVID-19 Vaccine 2024-2025 formula (Emergency Use Authorization)
Category
ETC
Indication(s)·Usage
  • To prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older
Effective components
SARS-CoV-2 spike protein(recombinant)(Host cell: Sf9, Vector: BV2705)

Active ingredient(s) and Contents

  • Effective components

    • SARS-CoV-2 spike protein(recombinant)(Host cell: Sf9, Vector: BV2705)

  • Other

    • Sodium dihydrogen phosphate monohydrate, Sodium chloride, Water for injections, Matrix-M, Disodium hydrogen phosphate heptahydrate, Polysorbate80, Sodium hydroxide, Hydrochloric acid

Dosage and administration

  • 1. Dosage
    For intramuscular injection
    1.1 Preparation of administration
    Novavax COVID-19 vaccine (2024-2025 formula) is a colorless to slightly yellow, transparent to slightly milky liquid formulation with no visible particles. Before administration, parenteral drugs should be visually inspected for particulate matters and discoloration depending on the solution and container, whenever possible. If particulate matters and discoloration are observed, the vaccine should not be administered.

    2. Administration
    0.5mL of Novavax COVID-19 vaccine (2024-2025 formula) is administered intramuscularly.
    2.1 Dose and schedule
    Individuals 12 Years of Age and Older Never Vaccinated with Any COVID-19 Vaccine
    Administer Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) as a series of two doses 3 weeks apart.
    Individuals 12 Years of Age and Older Vaccinated Only with One Dose of Any Novavax COVID-19 Vaccine, Adjuvanted
    Administer a single dose of Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) at least 3 weeks after the previous dose to complete the 2-dose series of Novavax COVID-19 Vaccine, Adjuvanted.
    Individuals 12 Years of Age and Older Vaccinated with Any COVID-19 Vaccine, Other than Novavax COVID-19 Vaccine, Adjuvanted, or with Two or More Doses of Novavax COVID-19 Vaccine, Adjuvanted.
    Administer a single dose of Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) at least 2 months after receipt of the last previous dose of COVID-19 vaccine.

Storage and handling

  • Keep in an air-tight container, out of direct light and under refrigeration conditions (2°C to 8°C), Do not freeze